Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
1.730
-0.230 (-11.73%)
Oct 3, 2025, 4:00 PM EDT - Market closed

Liminatus Pharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
-0.060.435.05-
Cash & Short-Term Investments
-0.060.435.05-
Cash Growth
--87.10%-91.40%--
Other Receivables
--0.130.10.05
Receivables
-3.670.950.10.05
Prepaid Expenses
-0.160.020.01-
Other Current Assets
-1.40.841.682.64
Total Current Assets
-5.282.246.842.69
Property, Plant & Equipment
-0000
Other Long-Term Assets
-0.13---
Total Assets
-5.412.246.842.69
Accounts Payable
-1.480.930.510.42
Accrued Expenses
03.10.860.440.33
Short-Term Debt
-19.9716.0516.513.18
Other Current Liabilities
-0.20.20.20.14
Total Current Liabilities
024.7518.0417.6514.07
Total Liabilities
024.7518.0417.6514.07
Common Stock
-4.714.714.170.27
Additional Paid-In Capital
04.614.615.165.56
Retained Earnings
-0-28.67-25.12-20.14-17.21
Shareholders' Equity
-0-19.34-15.79-10.81-11.38
Total Liabilities & Equity
-5.412.246.842.69
Total Debt
-19.9716.0516.513.18
Net Cash (Debt)
--19.92-15.62-11.45-13.18
Net Cash Per Share
--0.18-0.15-0.32-
Filing Date Shares Outstanding
26.01112.22112.2273.67-
Total Common Shares Outstanding
26.01112.22112.2273.67-
Working Capital
-0-19.47-15.8-10.81-11.38
Book Value Per Share
-0.00-0.17-0.14-0.15-
Tangible Book Value
-0-19.34-15.79-10.81-11.38
Tangible Book Value Per Share
-0.00-0.17-0.14-0.15-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q